NEW YORK (GenomeWeb News) – OralDNA Labs has licensed the rights to sell an Interleukin Genetics test that assesses the risk for periodontal disease, Interleukin said Wednesday.
 
Under the agreement, the oral diagnostics company has acquired a non-exclusive license allowing it to market, sell, and distribute Interleukin Genetics’ PST Genetic Test to dental practices in the US.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

British Nobel laureates and Fields Medal winners warn that a 'hard' Brexit could harm science across the UK, the Guardian reports.

Vox reports on inequities in genetic research and efforts to address them.

The New York Times reports that Arizona State University's Lawrence Krauss is retiring following allegations of sexual misconduct.

In PNAS this week: de novo NUS1 mutations linked to Parkinson's disease risk, candidate hepatocellular carcinoma drivers, and more.